- Home
- SNGX vs IHT Comparison
SNGX vs IHT Comparison
Compare SNGX & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- IHT
- Stock Information
- Founded
- SNGX 1987
- IHT 1971
- Country
- SNGX United States
- IHT United States
- Employees
- SNGX N/A
- IHT N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- SNGX Health Care
- IHT Finance
- Exchange
- SNGX Nasdaq
- IHT Nasdaq
- Market Cap
- SNGX 13.8M
- IHT 12.6M
- IPO Year
- SNGX 1987
- IHT N/A
- Fundamental
- Price
- SNGX $1.48
- IHT $1.29
- Analyst Decision
- SNGX Strong Buy
- IHT
- Analyst Count
- SNGX 1
- IHT 0
- Target Price
- SNGX $6.00
- IHT N/A
- AVG Volume (30 Days)
- SNGX 256.3K
- IHT 39.7K
- Earning Date
- SNGX 11-07-2025
- IHT 12-15-2025
- Dividend Yield
- SNGX N/A
- IHT 1.54%
- EPS Growth
- SNGX N/A
- IHT N/A
- EPS
- SNGX N/A
- IHT N/A
- Revenue
- SNGX N/A
- IHT $7,463,789.00
- Revenue This Year
- SNGX N/A
- IHT N/A
- Revenue Next Year
- SNGX N/A
- IHT N/A
- P/E Ratio
- SNGX N/A
- IHT N/A
- Revenue Growth
- SNGX N/A
- IHT N/A
- 52 Week Low
- SNGX $1.09
- IHT $1.26
- 52 Week High
- SNGX $6.23
- IHT $4.24
- Technical
- Relative Strength Index (RSI)
- SNGX 47.15
- IHT 32.82
- Support Level
- SNGX $1.25
- IHT $1.26
- Resistance Level
- SNGX $1.47
- IHT $1.50
- Average True Range (ATR)
- SNGX 0.11
- IHT 0.07
- MACD
- SNGX 0.02
- IHT -0.01
- Stochastic Oscillator
- SNGX 65.45
- IHT 10.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.